Back to top
more

Biosig Technologies (BSGM)

(Delayed Data from NSDQ)

$1.37 USD

1.37
95,748

+0.07 (5.38%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $1.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

The Cooper Companies (COO) Q3 Earnings Match Estimates

The Cooper Companies (COO) delivered earnings and revenue surprises of 0% and 3.31%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?

BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model

BioSig's (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.

Sientra (SIEN) Reports Q2 Loss, Lags Revenue Estimates

Sientra (SIEN) delivered earnings and revenue surprises of 3.41% and 7.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 25% and 7.60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Hologic (HOLX) Tops Q3 Earnings and Revenue Estimates

Hologic (HOLX) delivered earnings and revenue surprises of 5.68% and 2.85%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

BioSig (BSGM) Inks New Deal to Advance AI in Electrophysiology

The foundation of BioSig's (BSGM) AI medical device platform is set to be built upon integrated healthcare datasets.

The Zacks Analyst Blog Highlights ShockWave Medical, CheckCap and Biosig Technologies

ShockWave Medical, CheckCap and Biosig Technologies are part of The Zacks top Analyst Blog.

3 Medical Instruments Stocks With Potential to Outperform

Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.

Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates

Mesa Labs (MLAB) delivered earnings and revenue surprises of 18.09% and 6.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Neovasc (NVCN) Reports Q1 Loss, Misses Revenue Estimates

Neovasc (NVCN) delivered earnings and revenue surprises of -140.80% and 23.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Sensus Healthcare, Inc. (SRTS) Beats Q1 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 233.33% and 65.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 0.89% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Sorrento & ViralClear Explore Combination Coronavirus Treatments

Sorrento (SRNE) collaborates with ViralClear Pharmaceuticals to evaluate the combination of antibody and antiviral assets against COVID-19.

BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia

BioSig Technologies (BSGM) signs agreement with Mayo Foundation for improving arrhythmia treatment along with covering therapies for autonomic nervous system disease.

BioSig Technologies-Mayo Clinic Ink Electrophysiology Deal

This collaboration is expected to bolster BioSig's (BSGM) commitment toward offering higher quality patient care by introducing innovative technological solutions to medicine.

Moving Average Crossover Alert: Biosig Technologies, Inc.

Biosig Technologies could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.